摘要
目的:讨论雷贝拉唑+克拉霉素+阿莫西林疗法治疗胃溃疡的疗效。方法:2017年5月-2019年4月收治胃溃疡患者86例,随机分为两组。对照组采用奥美拉唑+克拉霉素+阿莫西林治疗;研究组采用雷贝拉唑+克拉霉素+阿莫西林治疗。比较两组治疗疗效、幽门螺杆菌(Hp)根治率及症状缓解评分。结果:研究组治疗总有效率及Hp根治率均高于对照组,研究组治疗后腹痛、腹胀及反酸嗳气临床症状缓解评分明显低于对照组,差异均有统计学意义(P<0.05)。结论:雷贝拉唑+克拉霉素+阿莫西林治疗方案可有效提高胃溃疡的治疗效果及Hp根治率,缓解各项临床症状。
Objective:To discuss the efficacy of rabeprazole,clarithromycin and amoxicillin in the treatment of gastric ulcer.Methods:86 patients with gastric ulcer were selected from May 2017 to April 2019.They were randomly divided into the two groups.The control group was treated with omeprazole,clarithromycin and amoxicillin,while the study group was treated with rabeprazole,clarithromycin and amoxicillin.The curative effect,Hp radical cure rate and symptom relief score of the two groups were compared.Results:The total effective rate and radical cure rate of Hp in the study group were higher than those in the control group.The relief scores of abdominal pain,abdominal distension and regurgitation in the study group were significantly lower than those in the control group,and the differences were statistically significant(P<0.05).Conclusion:Rabeprazole,clarithromycin and amoxicillin can effectively improve the therapeutic effect of gastric ulcer and the radical cure rate of Hp,and relieve the clinical symptoms.
作者
陈晓强
Chen Xiaoqiang(Department of Internal Medicine,Huangjing People's Hospital of Taicang City,Jiangsu Province,Jiangsu Taicang 215427)
出处
《中国社区医师》
2020年第2期57-58,共2页
Chinese Community Doctors
